Overall, these data demonstrate that ZEB1 knockdown decreases the viability of resistant melanoma cells in both MITFlow (RPMI7951, A375‐R, GOKA) and MITFhigh (SKMEL5‐R, ESP) cellular contexts. This evidence concerns the gene ZEB1 and melanoma.